title: Compensation, crosstalk and sequestering: the currency of checkpoints in cancer.
authors.affiliation: Department of Pathology and Laboratory of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
authors.forename: William K
authors.initials: WK
authors.lastname: Kaufmann
authors.forename: Carl W
authors.initials: CW
authors.lastname: Anderson
mesh_terms: D018797:Cell Cycle Proteins / Q000378:metabolism*; D004268:DNA-Binding Proteins / Q000378:metabolism*; D006801:Humans; D011494:Protein Kinases / Q000378:metabolism*; D054648:Protein Phosphatase 2 / Q000378:metabolism*; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism*; D025521:Tumor Suppressor Proteins / Q000378:metabolism*
chemical_list: D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D025521:Tumor Suppressor Proteins; D011494:Protein Kinases; D017346:Protein Serine-Threonine Kinases; D054648:Protein Phosphatase 2
keywords: DNA damage response; cancer therapy; cell cycle checkpoints; phosphatases; protein phosphorylation
references.citation: Cancer Lett. 2013 Jul 10;335(1):9-18
references.pmid: 23454242
references.citation: Trends Mol Med. 2011 Feb;17(2):88-96
references.pmid: 21087899
references.citation: Oncogene. 2010 Nov 11;29(45):5977-88
references.pmid: 20838380
references.citation: FEBS Lett. 2011 Jun 6;585(11):1625-39
references.pmid: 21570395
references.citation: Cell Cycle. 2013 Apr 1;12(7):1105-18
references.pmid: 23462183
references.citation: Drug Discov Today. 2012 Mar;17(5-6):194-202
references.pmid: 22192883
references.citation: Cell Cycle. 2010 Mar 1;9(5):995-1004
references.pmid: 20160494
references.citation: Oncogene. 2010 Jul 29;29(30):4317-29
references.pmid: 20498628